EXPERIMENTAL TYPE III PNEUMOCOCCUS PNEUMONIA IN MONKEYS : I. PRODUCTION AND CLINICAL COURSE
1Hospital of The Rockefeller Institute for Medical Research.
Abstract:
It has been possible by the intratracheal or intrabronchial inoculation of Type III Pneumococcus to produce in monkeys of the M. cynomolgos species an experimental pneumonia which in its clinical aspects closely resembles pneumococcus lobar pneumonia in man. The experimental disease is characterized by the development of a well localized pulmonary lesion of lobar distribution which tends to spread, the frequent occurrence of septicemia, a sustained fever, and the termination of the infection after a variable interval, in recovery or death of the animal. Wide variations in the severity of the disease in different monkeys have been noted. These variations appear to be due primarily to differences in the resistance of individual animals. The height of the septicemia accompanying the experimental pneumonia has been found to be the most valuable objective index of the probable outcome of the disease. Other factors which may influence the course and outcome of the disease are discussed.
Insights
Researchers created an experimental pneumonia in cynomolgus monkeys using Type III Pneumococcus. This model closely mimics human pneumococcus lobar pneumonia, offering insights into disease progression and outcomes.
Area of Science:
- * Infectious Diseases
- * Pulmonology
- * Veterinary Pathology
Background:
- * Pneumococcus lobar pneumonia is a significant human respiratory illness.
- * Animal models are crucial for understanding disease pathogenesis and testing interventions.
- * Previous models may not fully replicate the clinical and pathological features of human disease.
Purpose of the Study:
- * To establish and characterize an experimental model of pneumococcus lobar pneumonia in cynomolgus monkeys.
- * To investigate the clinical and pathological manifestations of induced pneumonia.
- * To identify potential indicators of disease severity and outcome.
Main Methods:
- * Intratracheal and intrabronchial inoculation of Type III Pneumococcus in *M. cynomolgos* monkeys.
- * Clinical observation of disease progression, including fever and general condition.
- * Pathological examination of pulmonary lesions and assessment of septicemia.
Main Results:
- * Successfully induced experimental pneumonia resembling human lobar pneumonia.
- * Observed localized lobar pulmonary lesions, septicemia, and sustained fever.
- * Noted significant variations in disease severity attributed to individual animal resistance.
- * Bacteremia levels correlated with disease outcome, serving as a key prognostic indicator.
Conclusions:
- * The experimental pneumonia model in cynomolgus monkeys accurately reflects key aspects of human pneumococcus lobar pneumonia.
- * Individual host resistance is a critical factor influencing disease severity.
- * Septicemia levels provide a valuable objective measure for predicting the outcome of experimental pneumococcal pneumonia.
More Related Videos
Related Concept Videos
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Atypical Pneumonia
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:


